Acadia Pharmaceuticals buy Citigroup Inc.
Start price
08.08.24
/
50%
€14.56
Target price
08.08.25
€21.06
Performance (%)
-5.53%
Price
14.08.24
€13.75
Summary
This prediction is currently active. With a performance of -5.53%, the BUY prediction by Citigroup_Inc_ is trending in the wrong direction. This prediction currently runs until 08.08.25. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Acadia Pharmaceuticals | -5.53% |
iShares Core DAX® | 2.722% |
iShares Nasdaq 100 | 4.546% |
iShares Nikkei 225® | 6.353% |
iShares S&P 500 | 3.194% |
Comments by Citigroup_Inc_ for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at Citigroup Inc. from $30.00 to $23.00. They now have a "buy" rating on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€14.59
09.05.24
09.05.24
€27.83
09.05.25
09.05.25
-5.76%
14.08.24
14.08.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€20.00
13.12.23
13.12.23
€35.17
13.12.24
13.12.24
-31.25%
14.08.24
14.08.24